RefleXion Medical is a biotargeting oncology company using each cancer’s unique biology as a means to reveal its location and then destroy it. Our journey began in 2009 with a simple question: if a cancer cell emits a signal, can we shoot right back to destroy it? Using biology to guide radiotherapy, we hope to have the means to turn cancer on itself. By leveraging positron emission tomography (PET), the gold standard in cancer imaging and staging in a novel way, RefleXion’s patented technology* causes tumors to continuously signal their location during radiotherapy delivery, potentially transforming radiotherapy from an early stage, local therapy into one suitable for metastatic disease. We’re passionately committed to making dramatic changes to cancer care, and we believe that small, lean teams of brilliant people are the only way to do that. We need teammates with both the foresight and experience to avoid roadblocks, and the drive and creativity to steer around those that inevitably appear. We seek those who will unabashedly and relentlessly help us create a new modality in cancer care. If you are bold and inventive – we want you. If you combine passion with experience – we want you. If you embrace iteration and constant learning – we want you. Come and join a company on a game-changing mission. Please visit https://www.reflexion.com/careers/ to learn more about current career opportunities. *The RefleXion X1 is approved for SBRT/SRT/IMRT. BgRT is pending regulatory review and is not commercially available.